GlassScriptPhysician profile
Jennifer P Wang
NPI 1003817776
$1,685.37
in general payments reported to CMS, 2019-2025
15 companies · $20.77 in 2025
The $20.77 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $552 · 2021: $223 · 2022: $276 · 2023: $80.83 · 2024: $83.44 · 2025: $20.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $701.07 | 2020-2023 | Tobradex St, Flarex |
| Merz North America, INC. | $212.39 | 2019 | |
| Alcon Vision LLC | $154.77 | 2019 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Imperative Care, INC | $110.86 | 2020 | |
| Allergan, INC. | $87.37 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $70.39 | 2019-2022 | |
| Gilead Sciences, INC. | $50.27 | 2024 | |
| Novartis Pharmaceuticals Corporation | $29.45 | 2023 | |
| Akorn, INC. | $23.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.01 | 2019 | |
| Abbvie INC. | $20.77 | 2025 | |
| Oyster Point Pharma, INC. | $19.58 | 2024 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Harrow Eye, LLC | $13.59 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.